11/8
01:12 am
elut
Low
Report
11/6
04:05 pm
elut
Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development
Medium
Report
Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development
10/24
12:21 pm
elut
Elutia (NASDAQ:ELUT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Elutia (NASDAQ:ELUT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/23
04:05 pm
elut
Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Low
Report
Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
10/14
04:05 pm
elut
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
Low
Report
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
10/10
08:08 am
elut
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors [Yahoo! Finance]
Low
Report
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors [Yahoo! Finance]
10/10
08:00 am
elut
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors
Low
Report
Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors
10/1
09:07 am
elut
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million [Yahoo! Finance]
Low
Report
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million [Yahoo! Finance]
10/1
08:41 am
elut
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
Medium
Report
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
9/16
08:00 am
elut
Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation
Medium
Report
Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation
9/10
12:35 pm
elut
Elutia (NASDAQ:ELUT) had its price target lowered by analysts at Lake Street Capital from $8.00 to $6.00. They now have a "buy" rating on the stock.
Low
Report
Elutia (NASDAQ:ELUT) had its price target lowered by analysts at Lake Street Capital from $8.00 to $6.00. They now have a "buy" rating on the stock.
9/9
08:54 am
elut
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million [Yahoo! Finance]
High
Report
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million [Yahoo! Finance]
9/9
08:30 am
elut
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million
High
Report
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million